Evidence map›Paper›PMID 42422819›Full record

ArticleFrontiers in medicine2026

Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial.

Run-Hua Li, Ying-Ying Yang, Wen Xu, Gui-Li Xia, Qing Cheng, Xiao-Bing Cui, Ying Zhu, Xiao-Hua Bao

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07176221 (Safety and Efficacy of Endoscopic Cardial Constriction Ligation (ECCL) With a Novel Disposable Endoscope), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07176221 nanot yet recruitingnot on this map

Safety and Efficacy of Endoscopic Cardial Constriction Ligation (ECCL) With a Novel Disposable Endoscope: A Multicenter Randomized Controlled Trial

TypeinterventionalSponsorYing ZhuRan2025 to 2028Enrolled46ConditionsGastroesophageal Reflux Disease (GERD)Armsendoscopic cardia constriction ligation
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Run-Hua Li *Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Ying-Ying Yang *Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China.
Wen XuDepartment of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Gui-Li XiaDepartment of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Qing ChengDepartment of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Xiao-Bing CuiDepartment of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Ying ZhuDepartment of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Xiao-Hua BaoDepartment of Gastroenterology, No. 964th Hospital, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Reusable endoscopes require reprocessing and may carry potential concerns regarding cross-contamination, whereas single-use endoscopes may reduce infection-related risks and simplify workflow. However, evidence remains limited on whether single-use endoscopes can provide comparable performance in therapeutic upper gastrointestinal procedures requiring stable visualization, reliable suction, retroflexion, and accessory compatibility. Endoscopic cardia constriction with ligation (ECCL) is a minimally invasive endoscopic treatment for refractory gastroesophageal reflux disease (GERD). This multicenter randomized controlled trial aims to compare the efficacy, safety, and procedural feasibility of ECCL performed with a single-use endoscope versus a reusable endoscope in patients with refractory GERD. Methods: This is a multicenter, open-label, parallel-group, non-inferiority randomized controlled trial. Ninety-eight adults aged 18-80 years with refractory GERD will be randomized 1:1 to undergo ECCL using either a single-use endoscope or a reusable endoscope. Eligible participants must have typical GERD symptoms for at least 6 months, persistent symptoms despite optimized acid-suppressive therapy, and objective evidence supporting GERD diagnosis. ECCL will be performed according to a standardized protocol. Participants will receive standardized post-procedural acid-suppressive therapy for 2 weeks and will be followed at 3 and 6 months. The primary efficacy endpoint is clinically significant symptom improvement, defined as a decrease in GERD-Q score of ≥4 points from baseline. Change in GERD-Q score will also be analyzed as a continuous supportive outcome. Secondary endpoints include procedural feasibility, safety outcomes, operational stability, device malfunction/defect rates, and acid-suppressive medication use after ECCL, including complete discontinuation of PPI/P-CAB therapy at 3 and 6 months. Discussion: This trial will provide prospective evidence on whether single-use endoscopes can support ECCL with efficacy, safety, and procedural feasibility comparable to reusable endoscopes. By integrating patient-reported outcomes, standardized procedural assessment, device-related events, and post-procedural medication use, this study may inform future clinical application of single-use endoscopes in therapeutic upper gastrointestinal endoscopy. Clinical trial registration: ClinicalTrials.gov, identifier NCT07176221.

Indexed as

disposable endoscopesendoscopic cardia constriction (ECCL)gastroesophageal reflux disease (GERD)infection controlprocedural feasibility and safetyrandomized controlled trialsingle-use endoscope

Identifiers

PMID42422819
PMCPMC13343349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.